Lippman Evan has filed 3 insider transactions across 1 company since May 2025.
Most recent transaction: a grant/award of 27347 shares of TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA) on March 04, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Lippman Evan | EVP, Business Development | A | Restricted Share Units | 27347 | $0.00 | 27,347.0000 | 1,163,000,000 | 9999.99% | 0.00% |
| May 14, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Lippman Evan | EVP, Business Development | A | Restricted Share Units | 47365 | $0.00 | 47,365.0000 | 1,159,000,000 | 9999.99% | 0.00% |
| May 14, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Lippman Evan | EVP, Business Development | A | Restricted Share Units | 148016 | $0.00 | 148,016.0000 | 1,159,000,000 | 9999.99% | 0.01% |